Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

192 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A multicenter study of ocular inflammation after COVID-19 vaccination.
Yasaka Y, Hasegawa E, Keino H, Usui Y, Maruyama K, Yamamoto Y, Kaburaki T, Iwata D, Takeuchi M, Kusuhara S, Takase H, Nagata K, Yanai R, Kaneko Y, Iwahashi C, Fukushima A, Ohguro N, Sonoda KH; JOIS Uveitis Survey Working Group. Yasaka Y, et al. Among authors: kusuhara s. Jpn J Ophthalmol. 2023 Jan;67(1):14-21. doi: 10.1007/s10384-022-00962-9. Epub 2022 Nov 22. Jpn J Ophthalmol. 2023. PMID: 36417027 Free PMC article.
Sweet's syndrome with panuveitis resembling Behçet's disease.
Matsumiya W, Kusuhara S, Yamada Y, Azumi A, Negi A. Matsumiya W, et al. Among authors: kusuhara s. Jpn J Ophthalmol. 2012 May;56(3):268-72. doi: 10.1007/s10384-012-0129-4. Epub 2012 Mar 8. Jpn J Ophthalmol. 2012. PMID: 22399310
Forskolin modifies retinal vascular development in Mrp4-knockout mice.
Matsumiya W, Kusuhara S, Hayashibe K, Maruyama K, Kusuhara H, Tagami M, Schuetz JD, Negi A. Matsumiya W, et al. Among authors: kusuhara h, kusuhara s. Invest Ophthalmol Vis Sci. 2012 Dec 7;53(13):8029-35. doi: 10.1167/iovs.12-10781. Invest Ophthalmol Vis Sci. 2012. PMID: 23154460 Free PMC article.
Background Factors Affecting Visual Acuity at Initial Visit in Eyes with Central Retinal Vein Occlusion: Multicenter Study in Japan.
Kondo M, Noma H, Shimura M, Sugimoto M, Matsui Y, Kato K, Saishin Y, Ohji M, Ishikawa H, Gomi F, Iwata K, Yoshida S, Kusuhara S, Hirai H, Ogata N, Hirano T, Murata T, Tsuboi K, Kamei M, Kinoshita T, Kuwayama S, Hirano Y, Ohta M, Kimura K, Takayama K, Takeuchi M, Takamura Y, Okamoto F, Mitamura Y, Terasaki H, Sakamoto T, Group OBOJCRSJ. Kondo M, et al. Among authors: kusuhara s. J Clin Med. 2021 Nov 29;10(23):5619. doi: 10.3390/jcm10235619. J Clin Med. 2021. PMID: 34884321 Free PMC article.
Multicenter, retrospective, observational study for the Treatment Pattern of systemic corticoSTERoids for relapse of non-infectious uveitis accompanying Vogt-Koyanagi-Harada disease or sarcoidosis.
Namba K, Takase H, Usui Y, Nitta F, Maruyama K, Kusuhara S, Takeuchi M, Azumi A, Yanai R, Kaneko Y, Hasegawa E, Nakai K, Tsuruga H, Morita K, Kaburaki T. Namba K, et al. Among authors: kusuhara s. Jpn J Ophthalmol. 2022 Mar;66(2):130-141. doi: 10.1007/s10384-021-00897-7. Epub 2022 Jan 19. Jpn J Ophthalmol. 2022. PMID: 35044561
Current practice in the management of ocular toxoplasmosis.
Yogeswaran K, Furtado JM, Bodaghi B, Matthews JM; International Ocular Toxoplasmosis Study Group; Smith JR. Yogeswaran K, et al. Br J Ophthalmol. 2023 Jul;107(7):973-979. doi: 10.1136/bjophthalmol-2022-321091. Epub 2022 Feb 23. Br J Ophthalmol. 2023. PMID: 35197262
Efficacy and Safety of Adalimumab for Exacerbation or Relapse of Ocular Inflammation in Patients with Vogt-Koyanagi-Harada Disease: A Multicenter Study.
Nakai S, Takeuchi M, Usui Y, Namba K, Suzuki K, Harada Y, Kusuhara S, Kaburaki T, Tanaka R, Takeuchi M, Mizuki N, Nakai K, Goto H, Herbort CP Jr. Nakai S, et al. Among authors: kusuhara s. Ocul Immunol Inflamm. 2024 May;32(4):367-375. doi: 10.1080/09273948.2022.2092007. Epub 2022 Jun 24. Ocul Immunol Inflamm. 2024. PMID: 35748779
192 results